@article{JTD13010,
author = {Houda Bahig and Hanbo Chen and Alexander V. Louie},
title = {Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {4},
year = {2017},
keywords = {},
abstract = {The notion that lobectomy is the standard treatment approach for operable early stage non-small cell cancer (ES-NSCLC) was recently challenged by the results from a combined analysis of two prematurely closed randomized controlled trials (STARS and ROSEL trials; NCT00840749 and NCT00687986) (1). In this study, Chang et al. pooled data from 58 patients with operable T1–2a (},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/13010}
}